{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:37:34Z","timestamp":1790696254065,"version":"4.1.0"},"reference-count":40,"publisher":"S. Karger AG","issue":"6","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Arch Allergy Immunol"],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>After the advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the outbreak of coronavirus disease 2019 (COVID-19) commenced across the world. Understanding the Immunopathogenesis of COVID-19 is essential for interrupting viral infectivity and preventing aberrant immune responses before a vaccine can be developed. In this review, we provide the latest insights into the roles of angiotensin-converting enzyme II (ACE2) and Ang II receptor-1 (AT1-R) in this disease. Novel therapeutic strategies, including recombinant ACE2, ACE inhibitors, AT1-R blockers, and Ang 1\u20137 peptides, may prevent or reduce viruses-induced pulmonary, cardiac, and renal injuries. However, more studies are needed to clarify the efficacy of these therapeutics. Furthermore, considering the common role of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway in AT1-R expressed on peripheral tissues and cytokine receptors on the surface of immune cells, potential targeting of this pathway using JAK inhibitors (JAKinibs) is suggested as a promising approach in patients with COVID-19 who are admitted to hospitals. In addition to antiviral therapy, potential ACE2- and AT1-R-inhibiting strategies, and other supportive care, we suggest other potential JAKinibs and novel anti-inflammatory combination therapies that affect the JAK-STAT pathway in patients with COVID-19. Since the combination of MTX and baricitinib leads to outstanding clinical outcomes, the addition of baricitinib to MTX might be a potential strategy.<\/jats:p>","DOI":"10.1159\/000508247","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:00:35Z","timestamp":1589216435000},"page":"467-475","source":"Crossref","is-referenced-by-count":155,"title":["JAK Inhibition as a New Treatment Strategy for Patients with COVID-19"],"prefix":"10.1159","volume":"181","author":[{"given":"Farhad","family":"Seif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Aazami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khoshmirsafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh","family":"Mohsenzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Pornour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001737"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1470320311402109"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002615200"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00005"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00253-07"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.310509"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.3.682"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22211.2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000504167"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.10.013"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0177-y"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310476"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.167"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206478"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507247"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30132-8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key432"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8021"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-1-5"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.08.010"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.06.014"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2007.02.014"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126363"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130078"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.07.004"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00753.x"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24406"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5RU0519-145R"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31618-5"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/art.39953"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S192440"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4221-0"}],"container-title":["International Archives of Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/508247","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/508247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:08:38Z","timestamp":1745410118000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000508247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,11]]},"published-print":{"date-parts":[[2020,6,16]]}},"URL":"https:\/\/doi.org\/10.1159\/000508247","archive":["Portico"],"relation":{},"ISSN":["1018-2438","1423-0097"],"issn-type":[{"value":"1018-2438","type":"print"},{"value":"1423-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}